The library currently houses over 950 master English instruments, with roughly 1,000 of the available translations already paired with version-specific certificates and full submission documentation. By storing these assets at the instrument-version level rather than the study level, the company allows sponsors to deploy validated content immediately without repeating linguistic reviews or certification workflows. This shift addresses a persistent bottleneck that frequently stalls the startup phase of global research.

Sanjiv Waghmare, chief product officer at Signant, noted that this repository allows teams to resolve translation requirements even before a study protocol is finalized. The library currently offers the deepest coverage in oncology, dermatology, and central nervous system research, with new validated instruments added continuously to support the company’s broader clinical evidence generation suite.